Table 5.

OR of NHL according to family history of nonhemolymphopoietic cancers in first-degree relatives (Italy, 1999-2002)

Cancer siteNHLControlsOR* (95% CI)OR (95% CI)
Oral cavity/pharynx7171.0 (0.4-2.4)1.0 (0.4-2.6)
Esophagus432.6 (0.6-12.1)2.7 (0.6-12.8)
Stomach10240.8 (0.4-1.6)1.1 (0.5-2.3)
Colorectum10300.7 (0.3-1.6)0.8 (0.4-1.7)
Liver18202.3 (1.2-4.6)2.1 (1.0-4.2)
Pancreas461.1 (0.3-4.3)1.3 (0.4-5.2)
Larynx05
Lung24431.3 (0.8-2.3)1.4 (0.8-2.4)
Skin341.7 (0.4-7.9)2.1 (0.4-10.2)
Breast22281.9 (1.0-3.5)2.0 (1.0-3.6)
Uterus7170.8 (0.3-2.1)0.8 (0.3-2.0)
Prostate481.1 (0.3-3.7)1.3 (0.4-4.5)
Bladder240.9 (0.2-5.3)0.8 (0.1-4.9)
Kidney534.5 (1.0-20.2)4.6 (1.0-20.9)
Brain and central nervous system261.0 (0.2-5.1)1.3 (0.2-6.8)
All sites
    Any1081851.6 (1.2-2.3)1.7 (1.2-2.4)
    1 relative721301.5 (1.1-2.2)1.5 (1.0-2.2)
    2 relatives24371.9 (1.1-3.4)2.0 (1.1-3.7)
    3 or more12182.0 (0.9-4.4)2.4 (1.0-5.6)
All sites excluding hemopoietic cancers
    Any1011801.5 (1.1-2.1)1.5 (1.1-2.2)
    1 relative701291.4 (1.0-2.1)1.4 (1.0-2.1)
    2 relatives20331.7 (0.9-3.3)1.8 (1.0-3.4)
    3 or more11181.7 (0.7-3.8)2.0 (0.9-4.8)
  • * OR adjusted for age, sex, and study center. Reference category: no family history.

  • OR adjusted for age, sex, study center, years of education, place of birth, seropositivity for hepatitis C virus, and number of brothers, sisters, sons, and daughters. Reference category: no family history.